Related Experiment Video
Updated: Jul 16, 2026
07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome
Hadi A R Hadi1, Cornelia S Carr, Jassim Al Suwaidi
1Department of Cardiology and Cardiovascular Surgery, Hamad General Hospital - Hamad Medical Corporation, Doha, State of Qatar.
Vascular Health and Risk Management
|February 27, 2007
Summary
Endothelial dysfunction, a precursor to atherosclerosis, involves nitric oxide imbalance and promotes lesion formation. Treating cardiovascular risk factors can reverse this dysfunction, improving cardiac outcomes.
Area of Science:
- Cardiovascular Science
- Pathophysiology
Background:
- Endothelial dysfunction is a key response to cardiovascular risk factors.
- It precedes atherosclerosis development and plays a role in lesion formation.
- It involves mechanisms like leukocyte adherence and LDL oxidation.
Purpose of the Study:
- To review the literature on endothelial dysfunction.
- To explore its pathogenesis, treatment, and clinical outcomes.
Main Methods:
- Literature review of studies on endothelial dysfunction.
- Analysis of its role in atherosclerosis and response to risk factor treatment.
Main Results:
- Endothelial dysfunction involves nitric oxide deficiency and imbalance of vasoactive factors.
- It promotes atherosclerosis through multiple cellular and molecular mechanisms.
- Reversal of endothelial dysfunction is possible with risk factor treatment.
Conclusions:
- Endothelial dysfunction is a critical early event in atherosclerosis.
- It is an independent predictor of cardiac events.
- Therapeutic interventions targeting cardiovascular risk factors can improve endothelial function and prognosis.
More Related Videos
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...